420 related articles for article (PubMed ID: 15606684)
1. Insulino-mimetic and anti-diabetic effects of vanadium compounds.
Srivastava AK; Mehdi MZ
Diabet Med; 2005 Jan; 22(1):2-13. PubMed ID: 15606684
[TBL] [Abstract][Full Text] [Related]
2. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
Mehdi MZ; Srivastava AK
Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
[TBL] [Abstract][Full Text] [Related]
3. Insulin signal mimicry as a mechanism for the insulin-like effects of vanadium.
Mehdi MZ; Pandey SK; Théberge JF; Srivastava AK
Cell Biochem Biophys; 2006; 44(1):73-81. PubMed ID: 16456236
[TBL] [Abstract][Full Text] [Related]
4. [Vanadium compounds--a new class of therapeutic agents for the treatment of diabetes mellitus].
Beliaeva NF; Gorodetskiĭ VK; Tochilkin AI; Golubev MA; Semenova NV; Kovel'man IR
Vopr Med Khim; 2000; 46(4):344-60. PubMed ID: 11075417
[TBL] [Abstract][Full Text] [Related]
5. Vanadium compounds as insulin mimics.
Orvig C; Thompson KH; Battell M; McNeill JH
Met Ions Biol Syst; 1995; 31():575-94. PubMed ID: 8564818
[TBL] [Abstract][Full Text] [Related]
6. Oral insulin-mimetic compounds that act independently of insulin.
García-Vicente S; Yraola F; Marti L; González-Muñoz E; García-Barrado MJ; Cantó C; Abella A; Bour S; Artuch R; Sierra C; Brandi N; Carpéné C; Moratinos J; Camps M; Palacín M; Testar X; Gumà A; Albericio F; Royo M; Mian A; Zorzano A
Diabetes; 2007 Feb; 56(2):486-93. PubMed ID: 17259395
[TBL] [Abstract][Full Text] [Related]
7. Vanadium salts as insulin substitutes: mechanisms of action, a scientific and therapeutic tool in diabetes mellitus research.
Sekar N; Li J; Shechter Y
Crit Rev Biochem Mol Biol; 1996 Dec; 31(5-6):339-59. PubMed ID: 8994801
[TBL] [Abstract][Full Text] [Related]
8. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
9. Arylalkylamine vanadium salts as new anti-diabetic compounds.
Zorzano A; Palacín M; Marti L; García-Vicente S
J Inorg Biochem; 2009 Apr; 103(4):559-66. PubMed ID: 19246098
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent?
Cam MC; Brownsey RW; McNeill JH
Can J Physiol Pharmacol; 2000 Oct; 78(10):829-47. PubMed ID: 11077984
[TBL] [Abstract][Full Text] [Related]
11. The insulin-like properties of vanadium: a curiosity or a perspective for the treatment of diabetes?
Brichard SM; Lederer J; Henquin JC
Diabete Metab; 1991; 17(5):435-40. PubMed ID: 1752343
[TBL] [Abstract][Full Text] [Related]
12. Insulino-mimetic and anti-diabetic effects of zinc.
Vardatsikos G; Pandey NR; Srivastava AK
J Inorg Biochem; 2013 Mar; 120():8-17. PubMed ID: 23266931
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
Goldfine AB; Patti ME; Zuberi L; Goldstein BJ; LeBlanc R; Landaker EJ; Jiang ZY; Willsky GR; Kahn CR
Metabolism; 2000 Mar; 49(3):400-10. PubMed ID: 10726921
[TBL] [Abstract][Full Text] [Related]
14. Treatment of diabetes with vanadium salts: general overview and amelioration of nutritionally induced diabetes in the Psammomys obesus gerbil.
Shafrir E; Spielman S; Nachliel I; Khamaisi M; Bar-On H; Ziv E
Diabetes Metab Res Rev; 2001; 17(1):55-66. PubMed ID: 11241892
[TBL] [Abstract][Full Text] [Related]
15. Effects of vanadium complexes with organic ligands on glucose metabolism: a comparison study in diabetic rats.
Reul BA; Amin SS; Buchet JP; Ongemba LN; Crans DC; Brichard SM
Br J Pharmacol; 1999 Jan; 126(2):467-77. PubMed ID: 10077240
[TBL] [Abstract][Full Text] [Related]
16. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice.
Mueller AS; Pallauf J
J Nutr Biochem; 2006 Aug; 17(8):548-60. PubMed ID: 16443359
[TBL] [Abstract][Full Text] [Related]
17. A novel insulin sensitizer (S15511) enhances insulin-stimulated glucose uptake in rat skeletal muscles.
Jessen N; Selmer Buhl E; Pold R; Schmitz O; Lund S
Horm Metab Res; 2008 Apr; 40(4):269-75. PubMed ID: 18548386
[TBL] [Abstract][Full Text] [Related]
18. Diabetes-altered gene expression in rat skeletal muscle corrected by oral administration of vanadyl sulfate.
Willsky GR; Chi LH; Liang Y; Gaile DP; Hu Z; Crans DC
Physiol Genomics; 2006 Aug; 26(3):192-201. PubMed ID: 16684804
[TBL] [Abstract][Full Text] [Related]
19. Insulin sensitivity in streptozotocin-induced diabetic rats treated with different doses of 17beta-oestradiol or progesterone.
Ordóñez P; Moreno M; Alonso A; Fernández R; Díaz F; González C
Exp Physiol; 2007 Jan; 92(1):241-9. PubMed ID: 17068109
[TBL] [Abstract][Full Text] [Related]
20. Anti-diabetic effects of sodium 4-amino-2,6-dipicolinatodioxovanadium(V) dihydrate in streptozotocin-induced diabetic rats.
Li M; Smee JJ; Ding W; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):585-9. PubMed ID: 19203797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
